Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Red Propolis as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease

NCT07597005 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.

NCT NCT07597005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07597005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Red Propolis as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease
Lead sponsor
Universidade Federal Fluminense
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2025
Completion date
August 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, inflammation, kidney disease, oxidative stress